Bing

SEARCH HISTORY

VIVUS, Inc. (NASDAQ:VVUS) announced on Tuesday that it was going to raise capital in a shares sale for up to 8.5 million shares. We had written last week that we expected the company to raise capital any day. Demand must have been very strong …
24/7 Wall ST · 3/1/2012
Lakeway, NY — (MARKET NEWS CALL) — 03/16/2015— Specialpennystockalert.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market about ... Inc. (NASDAQ:VVUS). Novavax, Inc.
Market News Call · 3/16/2015
VVUS): The maker of diet drug Qsymia is upgraded to Outperform from Market Perform at Cowen. As a result its shares, up 8.64% in yesterday's down market, are adding to gains ahead of the open. VMware (NYSE:VMW): FBN Securities takes the tech …
Minyanville · ByJustin Sharon · 10/3/2013
Juniper Networks Inc. (NYSE: JNPR): JPMorgan upgraded the stock to "overweight" from "neutral". Shares added 1.01 percent to trade at $21.20. VIVUS Inc. (NASDAQ: VVUS): Brean Capital downgraded the stock to "sell" from "hold". Shares lost 5.73 …
istock Analyst · 1/17/2013
Vivus’s (NASDAQ: VVUS) weight loss pill Qnexa, which awaits clearance from U.S Regulators, is thought to cause psychiatric and cardiovascular side effects and hasn’t been sufficiently tested in pregnant women. Study participants taking high doses of ...
TransWorldNews · 7/14/2010
A race to be the most popular obesity drug made for some abrupt stock moves on Wall Street Thursday, with three companies jockeying for position among investors. Vivus Inc. /quotes/zigman/56708 /quotes/nls/vvus VVUS held a wide lead, thanks to a …
Market Watch Commentary · ByRuss Britt · 10/3/2013
Manhattan, NY- June 20, 2015 – (Techsonian) – Cytori Therapeutics Inc (NASDAQ:CYTX) a biotechnology company, develops cell therapeutics for specific diseases and medical conditions. The company primarily provides Cytori Cell Therapy compriseing …
Techsonian · 6/20/2015
VIVUS, Inc. (NASDAQ:VVUS) VIVUS Inc is another volume active stock of Biotechnology Industry. VIVUS, Inc. is a biopharmaceutical company. VIVUS, Inc. (NASDAQ:VVUS) dropped -7.27% and closed at $22.39 with the total traded volume of 11.17 …
Property Mentor Group · 7/24/2012
Skechers USA Inc. SKX-1.02 % topped the list of Biggest Percentage Price Gainers among common stocks on the New York Stock Exchange at midday. See the full list. VIVUS Inc. VVUS-3.41 % topped the list of Biggest Percentage Price Gainers …
Wall Street Journal · 11/21/2012
Investors are jumping on the Vivus (VVUS) bandwagon. Shares of the pharmaceutical company were up 12.5% in early trading Wednesday, after the company late Tuesday received governmental approval for its drug to combat obesity. The Vivus drug is …
Investors Business Daily · ByPete Barlas · 7/18/2012